PIVOT
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Neoplasia with IDH1 Mutation
| Studienleiter | Dr. med. Jan Moritz Middeke |
| EudraCT-Nr. | 2023-509055-14-00 |
| Studientyp | Offen, Phase II |
| Indikation | Patients with Acute Myeloid Leukemia or Myelodysplastic Neoplasia with IDH1 Mutation |
| ClinicalTrial | NCT06717958 |